July 1, 2017 – June 30, 2018 Funding Cycle

PLEASE NOTE NEW POLICY

Due to the overwhelming response of our exceptional New Investigator Research Program,
the Leukemia Research Foundation will be implementing a 2 step application process:

1. LOI - Letter of Intent Due February 1, 2017 
(See specific instructions below)
2. Notification sent for Request for Full Proposal Due February 15, 2017

If you are notified and invited to submit a full proposal,
the project outline will be due:

March 15, 2017

A Letter of Inquiry allows the Leukemia Research Foundation to quickly assess if there is a good match between LRF's goals and the project. If it appears to be a good match, we will request a full proposal.

Technique

 Letters of Intent or Inquiry are generally 2–3 pages.

Please Follow This Format:

1. Abstract (250 words)

  • The abstract is the most important component of the LOI. Spend time developing the best possible title.
    The length must be no more than 250 words.
  • Use bold subheadings. Include highlights in the topic sentence in each section of the LOI. 
  • What will be done, by whom, how, over what period of time? What is the problem/need? Who will the outcomes benefit? 

2. Statement of Need: The "why" of the project. (1–2 paragraphs)

  • What is the issue that you are addressing and why does it matter?
  • Why is what you propose necessary? What is the void in knowledge? 
  • Who benefits? Indicate the public good, not just the effect on campus. 
  • Why hasn't this issue been addressed sufficiently in the past? Who else is working in this field, what have they done, and why isn't that enough? Demonstrate your knowledge of the field.
  • Provide convincing evidence that what you are proposing does not duplicate other work. Replication of someone else's work in a new environment or larger scale may be fundable.

3. Project Activity: The "what" and "how" of the project. (The bulk of your letter)

  • Why did you choose to address the issue in the manner that you have? Are there other approaches? If so, why aren't they appropriate to the situation?
  • What are the specific activities involved? Who will do them? 
  • Present a timeline of activities. Tables and charts work best here. They crystallize data, break up pages of narrative, and convey extensive information well in a limited space.
  • What specific outcomes will be achieved? What will change? 
  • Why are you/your organization the best one to do what you propose to do? Is it an extension of successful, innovative work or a pilot project you already completed?

4. Outcomes/Evaluation (1–2 paragraphs; before or after the Project Activity)

  • Essential piece that should be both quantitative and qualitative, if feasible.
  • Outline clearly the methodology that you will use to assess the project’s success.

5. Credentials (NIH biosketch)

6. Budget (click here)

7. Current and pending grant support

8. Closing (1 paragraph)

9. Signature

Application Information


APPLICATION INFORMATION - ONCE YOU HAVE BEEN INVITED TO APPLY

Applications are by invitation only. If you have been invited to apply (SEE ABOVE), please use this form for submission. The PDF has been set up so that you can complete and save the information on your computer. The deadline for submission is 11:59 p.m. Central Standard Time, on Wednesday, March 15, 2017. Applications that are received by the deadline will be reviewed by the Leukemia Research Foundation's independent Medical Advisory Board by June 2017. Results will not be available prior to this date. Leukemia Research Foundation reviewers do not prepare written reviews.

The Leukemia Research Foundation currently funds New Investigator grants only.

  • The amount is up to $100,000

  • The grant period is one year

  • Funding cycle begins on July 1, 2017

Applicants are not required to be U.S. citizens. Research projects undertaken outside the U.S. will be considered. If you have further questions after reading these guidelines please contact our Research Grants Administrator.

BACK TO TOP


ELIGIBILITY f

  • Preference given to proposals that focus on leukemia, lymphoma, MDS, and multiple myeloma.

  • New Investigators are considered to be within seven (7) years of their first independent position. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years. Questions regarding eligibility should be directed to our Research Grants Administrator.

  • Adjustments for career interruptions can be made. These could include but are not limited to, family leave, military service, major illness or injury. It is the responsibility of the applicant to point out and document such interruptions.

  • Investigators at the instructor level or similar position must include a letter from the department chair confirming their independence. The letter should also describe the facilities and resources available to the applicant.

  • Applicants with an NIH KO8 or K23 are eligible.

Exclusions

  • DOE, DOD, NSF, R21, or other grants with less than $175,000 per year in total direct costs are permitted. (Multiple grants which, when added together, have a total of $175,000 or more per year in total direct costs are excluded.)

  • NIH RO1 funding, VA Merit Award or equivalent.

  • Career development awards from other national foundations, (ACS, ASH, Burroughs Wellcome, Kimmel Scholar, etc.).

  • Any single grant of $175,000 or greater in total direct costs per year.

  • Renewal applications will not be accepted.

BACK TO TOP


FUNDING SPECIFICS

  • The Leukemia Research Foundation's policy does not provide funds for capital equipment (i.e. equipment purchases in excess of $5,000). Any request for exception to this policy must detail clearly the specific need of the capital equipment for the proposed research project.

  • The Leukemia Research Foundation does not provide salary support for the principal investigator.

  • Using funds for research travel is permitted but should not exceed $1,000. This money is intended only to enhance the study.

  • All other support for the project must be clearly detailed including all sources for the requested and related projects. Clearly indicate funding overlap.

  • All previous support from the Leukemia Research Foundation must be clearly stated; please list the title of the project, period(s) of support, and amount of award.

  • The LRF does not provide indirect cost recovery or institutional overhead costs.

BACK TO TOP


SUBMISSION INFORMATION

  • The submission deadline for the 2017-2017 funding cycle is March, 15, 2017.

  • Applications should be e-mailed to: Grants@LRFMail.org. All applicants will receive a receipt via e-mail when their application is received.

  • Grants will only be accepted electronically; hard copies of grant applications will not be accepted.

BACK TO TOP


APPLICATION SPECIFICS

  • Document format should be single spaced with a 12 point font used throughout. The paper size should be 8 1/2 inches by 11 inches.

  • A concise one paragraph description of the project is to be included in the application as a separate page. This paragraph should be in extreme lay terminology, appropriate for an audience without scientific training. Explain terms which cannot be simplified.

  • Your PDF file cannot exceed 10 MB in size. If it is larger than 10 MB please make arrangements with Linda Kabot, Research Grants Administrator, to accept it.

  • Application label should read as follows: LastName, FirstName, MiddleInitial. For example: Doe, Jane, N.pdf

  • You must use the 2017-2018 application cover sheet. This form must be filled out in its entirety for an application to be accepted and assigned for review.

  • The Medical Advisory Board will not consider unsolicited applications, or those that are incomplete.

BACK TO TOP


NOTIFICATION OF RESULTS

All completed applications for the 2017-2018 funding cycle will be reviewed by the Leukemia Research Foundation's independent Medical Advisory Board in early June. The Foundation approves applications for funding based on the recommendation of this panel. Notification will be e-mailed to applicants by June 30, 2017. Results will not be available prior to this date. Leukemia Research Foundation reviewers do not prepare written reviews.

BACK TO TOP


REPORTING REQUIREMENTS

  • The Final Scientific Report should be received within 30 days of completion of the project.

  • Grantees are required to complete the Final Scientific Report Form and e-mail the Foundation with a brief scientific summary, a brief lay summary, and a list of any resulting publications.

NOTE: This policy will be adhered to with no exceptions.

BACK TO TOP


DOWNLOAD THE APPLICATION COVER SHEET

Download the 2017-2018 application form here. A Microsoft Word version is available for download here.

The latest version of Acrobat Reader is required to open the application cover sheet. It is available for free by clicking the logo to the right:

BACK TO TOP

Stay Informed
Sign up for e-newsletters, major
events and research alerts!

191 Waukegan Road, Ste 105, Northfield, IL 60093  |  Office: 847.424.0600  |  Fax: 847.424.0606  |  Contact Us